# name
The burden of latent multidrug-resistant tuberculosis

# metadata.dc.description.abstract[].value
In the past 10 years, there has been renewed interest in the early phases of the natural history of tuberculosis.1 Estimates suggest that around 25% of the world's population could have latent tuberculosis infection,2 5–10% of whom will develop active disease during their lifetime3 (10% annually among people with HIV).4 Failure to implement effective tuberculosis control measures to manage latent infection threatens elimination goals.

# metadata.dc.relation.ispartof[].value
Lancet Infectious Diseases , 2019 , vol. , num. , p. 0

# metadata.dc.rights[].value
cc by-nc-nd (c) García-Basteiro et al., 2019

# metadata.dc.source[].value
Articles publicats en revistes (ISGlobal)

# metadata.dc.title[].value
The burden of latent multidrug-resistant tuberculosis